AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

S-Ventures Plc

Interim / Quarterly Report Sep 30, 2025

10309_rns_2025-09-30_21a06f51-a8dd-4f0c-be7a-0522eec1722d.html

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4636B

S-Ventures PLC

30 September 2025

30 September 2025

S-Ventures PLC

("S-Ventures", "Group" or the "Company")

Company Number: 12723377

Unaudited interim results for the six months ended 30 June 2025

The Directors of S-Ventures PLC are pleased to report on the half-year ended 30 June 2025.  These accounts are unaudited and have not been reviewed by an auditor.

Financial highlights

Six months ended

30 June 2025

£m
Six months ended

30 June 2024

£m
12 months to

31 December 2024

£m
Gross Revenues 6.7 8.0 15.2
EBITDA 1.9 0.8 0.7
Profit (Loss) from continuing operations 0.4 (0.5) (2.2)
Cash 0.2 0.7 0.3
Basic Earnings per Share (in pence per share) 0.31p (0.39p) (1.69p)

Operational highlights

The business was formed to invest in, acquire and grow businesses in the natural wellness food tech and organic snacking sector. The key points of this period are:

·    Net Sales for the six months of £5.2m are made up as follows:

6 months to

30 June 2025

£m
6 months to

30 June 2024

£m
12 months to

31 December 2024

£m
Gross Sales 6.7 8.0 15.1
Trade discounts, listing fees etc (1.5) (0.8) (1.2)
Net Sales 5.2 7.2 13.9

·    The results for our business segment analysis are:

Plant Based Nutrition

£'000
Bakery

£'000
Technical Services

£'000
Admin-istration

£'000
Total

£'000
Net Sales Revenues 1,293 3,099 771 - 5,163
Operating Profit / (Loss) before Tax (100) 118 (30) 495 483

Scott Livingston, CEO of S-Ventures, comments:

"I am pleased to report our interim results for the six months to 30 June 2025.

We have completed the disposal of substantially all of the operating subsidiaries in the Group to AIM quoted Tooru PLC and S-Ventures PLC holds 26.7% of the ordinary shares in Tooru PLC, which is the Company's principal asset.

In our opinion, the share prices of both companies don't represent the true value of the brands we are building but we have remained loyal to the public markets.

We expect to finalise a way forward to distribute the Tooru equity to shareholders. We are also looking for a deal for S- Ventures and there are many opportunities we are considering, largely in the same consumer and tech space.

The subsidiaries have performed in line with expectations, and the brands are building traction. As we move forward, our focus remains on maximising value for shareholders, whether through the distribution of our Tooru plc equity or through pursuing strategic opportunities that align with the Company".

Enquiries

S-Ventures PLC

Scott Livingston, Chief Executive Officer

+44 (0)20 3475 0230

VSA Capital Limited

Broker and Financial Advisor

Andrew Raca (Corporate Finance)

+44 (0) 20 3005 5000

Interim management report

Following the completion of the Reverse Takeover by Tooru plc of the five subsidiary businesses, Juvela, Pulsin, Market Rocket, We Love Purely and S-Ventures Acquisitions, on 28 May 2025, these accounts include the results of those subsidiaries for the first five months only.

As a result of this transaction, the Company has become a cash shell which, under Aquis Rules means it is an enterprise company. The principal assets of the Company are comprised of a 26.7% holding of ordinary shares in Tooru plc, a minority shareholding in Coldpress Foods Limited and a dormant subsidiary, Ohso Chocolate Limited.

By order of the Board

Scott Livingston               

Chief Executive Officer 

30 September 2025

Cautionary statement

This report contains forward-looking statements. These have been made by the directors in good faith based on the information available to them up to the time of their approval of this report. The directors can give no assurance that these expectations will prove to have been correct. Due to the inherent uncertainties, including both economic and business risk factors underlying such forward looking information, actual results may differ materially from those expressed or implied by these forward-looking statements. The directors undertake no obligation to update any forward-looking statements whether as a result of new information, future events or otherwise.

Consolidated Statement of Comprehensive Income (unaudited)

For the six months ended 30 June 2025

Six months ended 30 June 2025 Six months ended 30 June 2024 12 months to 31 December 2024
£'000 £'000 £'000
Gross Revenue 6,744 7,976 15,159
Less Trade discounts and Listing costs (1,581) (776) (1,239)
Net Sales Revenues 5,163 7,200 13,920
Cost of Sales (2,539) (3,220) (5,917)
Gross profit 2,624 3,980 8,003
Other operating income - - 10
Loss (Gain) on disposal 1,599 27 27
Administrative expenses (2,321) (3,165) (7,301)
(722) (3,138) (7,264)
EBITDA 1,902 842 739
Depreciation and amortisation (532) (715) (1,401)
Finance costs (874) (645) (1,287)
Finance income 1 3 7
Exceptional costs (13) - -
(1,419 (1,357) (2,681)
Loss before taxation 483 (515) (1,942
Income tax (71) - (258)
Profit (Loss) 412 (515) (2,200)
Loss after tax for discontinued operations (40)
Total comprehensive profit (loss) 412 (515) (2,240)

Consolidated Statement of Financial Position (unaudited)

As at 30 June 2025

As at 30

June 2025
As at 30

June 2024
As at 31 December 2024
£'000 £'000 £'000
ASSETS
Non-current
Goodwill - 3,462 3,643
Owned:
- Intangible assets - 7,204 6,570
- Property, Plant & Equipment 14 1,405 2,387
Right of Use:
- Property, Plant & Equipment - 1,523 943
Investments 3,530 30 31
Total non-current assets 3,544 13,624 13,574
Current assets
Inventories - 1,272 1,098
Trade and other receivables 603 2,619 2,808
Cash and cash equivalents 156 679 252
Total current assets 759 4,570 4,158
Assets from discontinued operations - - 20
TOTAL ASSETS 4,303 18,194 17,752
EQUITY
SHAREHOLDERS' Equity
Called Up Share capital 132 132 132
Share premium 14,708 14,708 14,708
Share based payment reserve - 8 8
Contingent equity settled consideration for investment - 112 112
Retained earnings (11,524) (11,654) (13,060)
3,316 3,306 1,900
Non controlling interests - (41) (77)
TOTAL EQUITY 3,316 3,265 1,823

Consolidated Statement of Financial Position (unaudited) - Cont'd

As at 30 June 2025

As at 30

June 2025
As at 30

June 2024
As at 31 December 2024
LIABILITIES
Current Liabilities
Trade and other payables 987 3,456 5,016
Financial Liabilities: - Borrowings
-Interest bearing loans and borrowings - 2,724 6,479
Lease liability - 1,811 159
987 7,991 11,654
Non-current Liabilities
Provision - 440 564
Lease liability - - 823
-Interest bearing loans and borrowings - 6,498 2,694
- 6,938 4,081
TOTAL LIABILITIES 987 14,929 15,735
NET EQUITY AND LIABILITIES 4,303 18,194 17,752

Consolidated cash flow statement (unaudited)

For the six months ended 30 June 2025

Six months ended 30

June 2025
Six months ended 30

June 2024
12 months to 31 December 2024
Cash flow from operating activities
Profit (Loss) for the period 292 (515) (2,240)
Finance costs 57 645 1,286
Finance income - (2) (7)
Profit on disposal of fixed assets - (47) (27)
Depreciation and Amortisation 3 715 1,401
Interest paid (57) (339) (577)
Lease interest paid - (39) -
Changes in Working Capital
Decrease/(Increase) in inventory - 585 758
Decrease/(Increase) in trade and other receivables (104) (689) 114
(Decrease)/Increase in trade and other payables (230) (960) (370)
Net cash flow from operating activities (39) (646) 338
Cash flow from investing activities
Cash received on sale of subsidiaries 420 - -
Cash and cash equivalents of subsidiaries sold (255) - -
Purchase of tangible fixed assets - (47) (1,007)
Net cash flow from investing activities 165 (47) (1,007)
Cash flow from financing activities
Proceeds from borrowings 50 1,091 771
Repayment of borrowings (25) (21) -
Repayment of lease liabilities - (9) (230)
Introduced/Withdrawn by directors - - 75
Net cash flow from financing activities 25 1,061 616
Net increase/(decrease) in cash and cash equivalents 151 368 (53)
Cash and cash equivalents at start of period 5 305 305
Cash and cash equivalents at end of period 156 673 252

Notes to the condensed consolidated financial statements (unaudited)

1.    General information

The consolidated financial statements for the six months ended 30 June 2025 are unaudited and were authorised for issue in accordance with a resolution of the Board of Directors.

2.  Basis of preparation

The financial information set out in this interim report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. The group's statutory financial statements for the period ended 31 December 2024, prepared under International Financial Reporting Standards (IFRS), have been filed with the Registrar of Companies.

The interim financial information has been prepared in accordance with the recognition and measurement principles of International Financial Reporting Standards (IFRS) and on the same basis and using the same accounting policies as used in the financial statements for the year ended 31 December 2024. The interim financial statements have not been audited or reviewed in accordance with the International Standard on Review Engagement 2410 issued by the Auditing Practices Board.

The financial statements have been prepared on a going concern basis under the historical cost convention.  This is considered to be an appropriate basis by the directors.

These condensed consolidated interim financial statements comprise the accounts of the parent company for the six months to 30 June 2025 and those of the five subsidiaries for the period from 1 January 2025 to their sale on 28 May 2025, after elimination of all material intercompany balances and transactions.

3.    Earnings per share:

The calculation of the total basic earnings per share of 0.31p is based on the profit attributable to equity owners of the company divided by the weighted number of shares in issue during the period.

4.    Investments:

The investment in shares in Coldpress Foods Limited is accounted for at cost.

5.    Approval of Interim Finance Statements:

These interim financial statements were approved by the Board of Directors on 30 September 2025.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXSDEFDSEISEDU

Talk to a Data Expert

Have a question? We'll get back to you promptly.